Teva Invites the Public to Listen to Its 2012 Investor Meeting Webcast

  Teva Invites the Public to Listen to Its 2012 Investor Meeting Webcast

Business Wire

JERUSALEM -- December 06, 2012

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) invites investors and the
general public to listen to a live audio webcast of its 2012 Investor Meeting
on Tuesday, December 11, 2012 at 12:00 p.m. ET.

        
What:      Teva’s 2012 Investor Meeting
           
Who:       Teva Management
           
When:      Tuesday, December 11, 2012 at 12:00 p.m. ET
           
Where:     www.tevapharm.com
           
           Live over the Internet -- log on to the Web at the address above
How:       and register for the event (approx. 10 minutes before). An archive
           of the webcast will be available on Teva's website.
           

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic drugs as
well as innovative and specialty pharmaceuticals and active pharmaceutical
ingredients. Headquartered in Israel, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,300 molecules and a
direct presence in about 60 countries. Teva's branded businesses focus on CNS,
oncology, pain, respiratory and women's health therapeutic areas as well as
biologics. Teva currently employs approximately 46,000 people around the world
and reached $18.3 billion in net revenues in 2011.

Contact:

IR:
Kevin C. Mannix
United States
215-591-8912
Joseph Marczely
United States
267-468-4281
Tomer Amitai
Israel
972 (3) 926-7656
or
PR:
Hadar Vismunski-Weinberg
Israel
972 (3) 926-7687
Denise Bradley
United States
215-591-8974
 
Press spacebar to pause and continue. Press esc to stop.